Cushing's disease requires accurate diagnosis, careful treatment selection, and long-term
management to optimise patient outcomes. The Pituitary Society convened a consensus …

Cushing's syndrome is defined by prolonged exposure to glucocorticoids, leading to excess
morbidity and mortality. Diagnosis of this rare pathology is difficult due to the low specificity …

In patients with Cushing's disease (CD), prompt diagnosis and treatment are essential for
favorable long-term outcomes, although this remains a challenging task. The differential …

Endogenous Cushing's syndrome (CS) is a rare multisystem disorder that results from
overproduction of the glucocorticoid hormone cortisol, whether due to corticotropin …

Decision-making in pituitary disease is critically dependent on high quality imaging of the
sella and parasellar region. Magnetic resonance imaging (MRI) is the investigation of choice …

Abstract Thyrotropin (TSH)-secreting adenomas (TSHomas) are the rarest form of pituitary
adenomas, and most endocrinologists will see few cases in a lifetime, if any. In most cases …

Background Corticotrophin-releasing hormone (CRH) is the major regulator of
adrenocorticotrophic hormone (ACTH) secretion from the anterior pituitary and acts via CRH …

The management of endogenous Cushing's syndrome (CS) typically involves two key
steps:(i) confirmation of autonomous hypercortisolism and (ii) localization of the cause to …

Cushing syndrome (CS) in childhood results mostly from the exogenous administration of
glucocorticoids; endogenous CS is a rare disease. The latter is the main reason pediatric …

Objective We report our experience of functional imaging with 11C-methionine positron
emission tomography–computed tomography (PET–CT) co-registered with 3D gradient echo …